grey market peptides retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide: Premium Research Peptide |

Medication is prepared by state-licensed compounding pharmacies separate from both the platform and the clinicians

This article delves into its mechanisms, clinical efficacy, dosing strategies, benefits, risks, and emerging research, providing a comprehensive overview of this innovative therapy

As a distance runner, Carly Anderson may be setting the pace for the future of GLPs

Benefits Significant, clinically proven weight loss Reduced risk of Type 2 diabetes, high blood pressure, and cardiovascular disease Non-surgical, once-weekly injection Personalized dosing not a one-size-fits-all approach Physician-supervised by a board-certified plastic surgeon Built-in path to body contouring if needed after weight loss Best candidates for GLP-1 weight loss injections GLP-1 type medications are suitable for adults who: Have a body mass index (BMI) of 30 or higher (obesity) Have a BMI of 27 or higher (overweight) with at least one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol